Flora Growth Corp. FLGC
We take great care to ensure that the data presented and summarized in this overview for Flora Growth Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FLGC
View all-
Trustcore Financial Services, LLC1KShares$1,0200.0% of portfolio
-
Global Financial Private Client, LLC Sarasota, FL249Shares$2530.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA99Shares$1000.0% of portfolio
-
Nelson, Van Denburg & Campbell Wealth Management Group, LLC Omaha, NE60Shares$610.0% of portfolio
Latest Institutional Activity in FLGC
Top Purchases
Top Sells
About FLGC
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.
Insider Transactions at FLGC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 15
2024
|
Edward Woo |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+27.07%
|
-
|
Dec 15
2024
|
Clifford Starke CEO |
BUY
Grant, award, or other acquisition
|
Direct |
900,000
+49.81%
|
-
|
Dec 15
2024
|
Sammy Dorf Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
Sep 13
2024
|
Clifford Starke CEO |
BUY
Open market or private purchase
|
Direct |
6,795
+49.81%
|
$0
$0.95 P/Share
|
Sep 06
2024
|
Harold Wolkin |
BUY
Open market or private purchase
|
Direct |
25,000
+40.28%
|
$0
$0.96 P/Share
|
Sep 05
2024
|
Clifford Starke CEO |
BUY
Open market or private purchase
|
Direct |
51
+0.01%
|
$0
$0.95 P/Share
|
Apr 08
2024
|
Clifford Starke CEO |
BUY
Open market or private purchase
|
Indirect |
526,315
+48.2%
|
$526,315
$1.9 P/Share
|
Nov 15
2023
|
Dany Vaiman CFO |
BUY
Grant, award, or other acquisition
|
Direct |
149,024
+46.59%
|
-
|
Nov 15
2023
|
Thomas Solomon |
BUY
Grant, award, or other acquisition
|
Direct |
35,766
+50.0%
|
-
|
Nov 15
2023
|
Edward Woo |
BUY
Grant, award, or other acquisition
|
Direct |
74,512
+46.8%
|
-
|
Nov 15
2023
|
Kevin Taylor Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
124,186
+50.0%
|
-
|
Nov 15
2023
|
Clifford Starke CEO |
BUY
Grant, award, or other acquisition
|
Direct |
327,851
+40.89%
|
-
|
Jun 25
2023
|
Hussein Rakine |
SELL
Sale (or disposition) back to the issuer
|
Direct |
82,100
-97.04%
|
-
|
May 18
2023
|
Cohen, Matthew S. General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
90,146
-21.48%
|
$0
$0.24 P/Share
|
Apr 16
2023
|
Hussein Rakine |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+41.49%
|
-
|
Mar 17
2023
|
Brandon Konigsberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
Mar 17
2023
|
Juan Carlos Gomez Roa Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+6.84%
|
-
|
Mar 17
2023
|
Marc Mastronardi Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+48.39%
|
-
|
Mar 17
2023
|
Beverley Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
Mar 17
2023
|
John Timothy Leslie Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+47.43%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 1.2M shares |
---|---|
Open market or private purchase | 558K shares |